JD HEALTH INTL LTD (8ZN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, JD HEALTH INTL LTD (8ZN) has a cash flow conversion efficiency ratio of 0.004x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€184.04 Million ≈ $215.16 Million USD) by net assets (€48.69 Billion ≈ $56.93 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of JD HEALTH INTL LTD for the company's overall valuation and market capitalisation.
JD HEALTH INTL LTD - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how JD HEALTH INTL LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data.
JD HEALTH INTL LTD Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JD HEALTH INTL LTD ranked by their cash flow conversion efficiency. Explore JD HEALTH INTL LTD cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yara International ASA
OL:YAR
|
0.057x |
|
Jindal Steel & Power Limited
NSE:JINDALSTEL
|
0.065x |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
0.037x |
|
BUREAU VERITAS ADR EO-12
F:4BV0
|
N/A |
|
Zhejiang Nhu Co Ltd
SHE:002001
|
0.069x |
|
MAPFRE S.A.ADR 2 / EO-10
F:CMA
|
N/A |
|
Turkiye Garanti Bankasi A.S.
IS:GARAN
|
0.249x |
|
ZTO EXPRESS (CAYMAN)
F:ZTOB
|
N/A |
Annual Cash Flow Conversion Efficiency for JD HEALTH INTL LTD (2019–2025)
The table below shows the annual cash flow conversion efficiency of JD HEALTH INTL LTD from 2019 to 2025. View JD HEALTH INTL LTD (8ZN) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €60.07 Billion ≈ $70.23 Billion |
€10.17 Billion ≈ $11.89 Billion |
0.169x | +115.95% |
| 2024-12-31 | €55.24 Billion ≈ $64.58 Billion |
€4.33 Billion ≈ $5.06 Billion |
0.078x | -15.91% |
| 2023-12-31 | €49.37 Billion ≈ $57.72 Billion |
€4.60 Billion ≈ $5.38 Billion |
0.093x | -29.26% |
| 2022-12-31 | €44.78 Billion ≈ $52.36 Billion |
€5.91 Billion ≈ $6.90 Billion |
0.132x | +53.18% |
| 2021-12-31 | €39.85 Billion ≈ $46.59 Billion |
€3.43 Billion ≈ $4.01 Billion |
0.086x | -8.67% |
| 2020-12-31 | €39.25 Billion ≈ $45.89 Billion |
€3.70 Billion ≈ $4.33 Billion |
0.094x | +110.57% |
| 2019-12-31 | €-459.03 Million ≈ $-536.66 Million |
€409.47 Million ≈ $478.71 Million |
-0.892x | -- |
About JD HEALTH INTL LTD
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. Th… Read more